Monocytic Leukemia

• CLINICAL_TRIALS trial_result · 2026-04-13
  Clinical Trial Update: Decitabine, Cytarabine, and Daunorubicin Hydrochloride in Treating Patients With Acute Myeloid Leukemia [Phase 2]

  A Phase 2 clinical trial evaluating the combination of decitabine, cytarabine, and daunorubicin hydrochloride for treatment of Acute Myeloid…

• CLINICAL_TRIALS trial_result · 2025-04-29
  Clinical Trial Update: Sirolimus, Idarubicin, and Cytarabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia [EARLY_Phase 1]

  A Phase 1 trial evaluating a combination of sirolimus, idarubicin, and cytarabine in adults with newly diagnosed acute myeloid leukemia has …

• CLINICAL_TRIALS trial_result · 2024-10-24
  Clinical Trial Update: FT538 in Combination With Daratumumab in AML Acute Myeloid Leukemia [Phase 1]

  This Phase 1 trial evaluated FT538 in combination with daratumumab in acute myeloid leukemia, including monocytic leukemia, and has complete…

• CLINICAL_TRIALS trial_result · 2023-11-07
  Clinical Trial Update: Therapeutic Use of Intravenous Vitamin C in Allogeneic Stem Cell Transplant Recipients [Phase 2]

  Phase 2 trial update on intravenous vitamin C use in allogeneic stem cell transplant recipients, with completed status and posted results.

• CLINICAL_TRIALS trial_result · 2023-07-27
  Clinical Trial Update: Treateament of Newly Diagnosed Acute Monocytic Leukemia in Children [Phase 2, Phase 3]

  Clinical trial update for treatment of newly diagnosed acute monocytic leukemia in children, currently in Phase 2 and Phase 3.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2018-07-26
  Clinical Trial Update: AML Therapy With Irradiated Allogeneic Cells [NA]

  Clinical trial update for irradiated allogeneic cell therapy in various adult acute myeloid leukemia subtypes; the study is terminated with …

• CLINICAL_TRIALS trial_result · 2017-12-06
  Clinical Trial Update: MEK Inhibitor MEK162, Idarubicin, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia [Phase 1]

  A Phase 1 trial evaluating a MEK inhibitor (MEK162) in combination with idarubicin and cytarabine for adults with relapsed or refractory acu…

• CLINICAL_TRIALS trial_result · 2017-04-17
  Clinical Trial Update: Treatment for Relapsed/Refractory AML Based on a High Throughput Drug Sensitivity Assay [NA]

  Clinical trial update on using a high-throughput drug sensitivity assay to guide treatment for relapsed/refractory acute myeloid leukemia.

• CLINICAL_TRIALS trial_result · 2017-03-31
  Clinical Trial Update: Decitabine Followed by Idarubicin and Cytarabine in Treating Patients With Relapsed or Refractory AML and MDS [Phase 2]

  Phase 2 clinical trial evaluated a sequence of decitabine followed by idarubicin and cytarabine in adults with relapsed or refractory acute …

• CLINICAL_TRIALS trial_result · 2017-03-10
  Clinical Trial Update: Ixazomib (MLN9708) in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia [Phase 2]

  Phase 2 clinical trial update of ixazomib in relapsed or refractory acute myeloid leukemia has been terminated; results were posted previous…

• CLINICAL_TRIALS trial_result · 2016-05-09
  Clinical Trial Update: Omacetaxine Mepesuccinate, Cytarabine, and Decitabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia [Phase 2]

  Phase 2 trial evaluating a three-drug regimen of omacetaxine mepesuccinate, cytarabine, and decitabine in older adults with newly diagnosed …

• CLINICAL_TRIALS trial_result · 2015-06-19
  Clinical Trial Update: Cholecalciferol in Treating Patients With Acute Myeloid Leukemia Undergoing Intensive Induction Chemotherapy [Phase 2]

  Phase 2 trial evaluating cholecalciferol (Vitamin D3) in adults with acute myeloid leukemia undergoing intensive induction chemotherapy; the…

• CLINICAL_TRIALS trial_result · 2015-01-07
  Clinical Trial Update: AKT Inhibitor MK-2206 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia [Phase 2]

  Phase 2 trial evaluating AKT inhibitor MK-2206 in relapsed or refractory adult acute leukemias completed; results posted in 2015.

• CLINICAL_TRIALS trial_result · 2014-02-06
  Clinical Trial Update: Bortezomib and Combination Chemotherapy in Treating Younger Patients With Recurrent, Refractory, or Secondary Acute Myeloid Leukemia [Phase 2]

  A Phase 2 trial evaluating bortezomib in combination with chemotherapy for younger patients with recurrent, refractory, or secondary acute m…

• CLINICAL_TRIALS trial_result · 2013-09-19
  Clinical Trial Update: Entinostat and Sorafenib Tosylate in Treating Patients With Advanced or Metastatic Solid Tumors or Refractory or Relapsed Acute Myeloid Leukemia [Phase 1]

  A Phase 1 trial evaluating the combination of entinostat and sorafenib in patients with advanced or metastatic solid tumors or relapsed/refr…

• CLINICAL_TRIALS trial_result · 2013-06-04
  Clinical Trial Update: Combination Chemotherapy With or Without Valspodar in Treating Patients With Previously Untreated Acute Myeloid Leukemia [Phase 3]

  Phase 3 trial evaluating whether adding the P-glycoprotein modulator valspodar to standard chemotherapy improves outcomes in adults with pre…

• CLINICAL_TRIALS trial_result · 2013-02-05
  Clinical Trial Update: Bortezomib, Daunorubicin, and Cytarabine in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia [Phase 1, Phase 2]

  This update reports on a Phase 1/2 clinical trial evaluating the combination of bortezomib, daunorubicin, and cytarabine in older patients w…

• CLINICAL_TRIALS trial_result · 2013-01-24
  Clinical Trial Update: Idarubicin and Cytarabine With or Without Bevacizumab in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia [Phase 2]

  Phase 2 trial of idarubicin and cytarabine with or without bevacizumab for newly diagnosed acute myeloid leukemia was terminated.

• CLINICAL_TRIALS trial_result · 2013-01-11
  Clinical Trial Update: SB-715992 in Treating Patients With Acute Leukemia, Chronic Myelogenous Leukemia, or Advanced Myelodysplastic Syndromes [Phase 1]

  This Phase 1 trial evaluated SB-715992 in adults with various acute leukemias, chronic myeloid leukemia in blast phase, and advanced myelody…